The purified human placental insulin-receptor f-subunit autophosphorylating activity was found to be inhibited, in a time-and concentration-dependent manner, by the specific thiol-alkylating agents Nethylmaleimide and 5,5'-dithiobis-(2-nitrobenzoic acid). The insulin-receptor kinase was observed to be more sensitive to inhibition by N-ethylmaleimide in the presence [IC50 (concn. giving 50% inhibition) = 25 + 3 ,M] than in the absence (IC50 = 73 + 6 #sM) of insulin. Similarly, inhibition by 5,5'-dithiobis-(2-nitrobenzoic acid) occurred with IC50 = 30 + 6 /SM in the presence and 155 + 35/M in the absence of insulin. Examination of the exogenous-substrate protein kinase activity demonstrated that the differential sensitivity to Nethylmaleimide was due to direct inhibition of protein kinase activity, as opposed to blockade of the phospho-acceptor properties of the insulin receptor. In contrast, iodoacetamide had essentially no effect on the insulin-receptor ,-subunit autophosphorylating activity and was able to protect partially against the N-ethylmaleimide inhibition in both the presence and the absence of insulin. Consistent with these findings, none of the thiol-specific agents were able to alter significantly insulin binding at concentrations which maximally inhibited the f8-subunit autophosphorylation. Further, in the presence of insulin, the insulinreceptor kinase activity was also observed to be more sensitive to oxidation by H202 and FeCl3/ascorbate compared with insulin receptors in the absence of insulin. These results indicate that there is a critical thiol group(s) necessary for the fl-subunit autophosphorylating activity of the insulin-receptor kinase and that in the presence of insulin is more susceptible to exogenously added thiol and oxidizing agents.
INTRODUCTION
The insulin receptor has been well established to exist minimally as a heterotetrameric disulphide-linked complex consisting of two Mr-130000 (a) and two (,O) subunits Massague et al., 1981; Van Obberghen et al., 1981; Fujita-Yamaguchi, 1984; Boyle et al., 1985) . It is thought that the a subunit encompasses the high-affinity insulin-binding site (Yip et al., 1978 Jacobs et al., 1979; Pilch & Czech, 1980; Yeung et al., 1980) , whereas the , subunit contains a single hydrophobic transmembrane domain (Ebina et al., 1985; Ullrich et al., 1985) , an intracellular ATPbinding site (Roth & Cassell, 1983; Van Obberghen et al., 1983) , as well as tyrosine-autophosphorylation receptor sites (Avruch et al., 1982; Kasuga et al., 1982a Kasuga et al., ,b,c, 1983a Petruzzelli et al., 1982 Petruzzelli et al., , 1984 Tamura et al., 1983; Zick et al., 1983) .
The insulin-receptor kinase has been observed to be activated by reducing agents, e.g. dithiothreitol (DTT) Fujita-Yamaguchi & Kathuria, 1985; Sweet et al., 1986) , and to be inhibited by the specific thiol-alkylating agent N-ethylmaleimide (NEM) Zick et al., 1983; Pike et al., 1984; Wilden et al., 1986) . We have also observed that the DTTdependent activation of the insulin-receptor kinase -is additive with that of insulin . Further, insulin was found to potentiate the DTTdependent reduction of the insulin-receptor a2f2 disulphide-linked complex, when analysed by SDS/polyacrylamide-gel electrophoresis. These observations strongly imply that intramolecular oxidationreduction reactions may be a possible regulatory mechanism for the intramolecular transmembrane-signal activation of the insulin-receptor kinase. In this paper, we report the effects of several thiol and oxidizing agents on the insulin-receptor fl-subunit autophosphorylating activity. These results suggest that insulin induces an alteration of the insulin-receptor structure which results in a greater susceptibility of a critical thiol group(s) to thiol and oxidizing agents. full-term human placenta as previously described (Boyle et al., 1985; Sweet et al., 1985) . Briefly, placental membranes were prepared as described by Harrison & Itin (1980 (Cuatrecasas, 1972) . Non-specific binding, determined in the presence of 15,M unlabelled insulin, ranged from 3 to 5% of the total binding.
EXPERIMENTAL
Exogenous-substrate phosphorylation Insulin receptors were treated as described in the Figure legends , and the kinase reactions were initiated by the addition of 0.1 mg of poly(Glu: Tyr) (4:1) and [y-32P]ATP (1.0 mM-ATP, 3 ,Ci/nmol), as previously described. The reactions were terminated by the addition of samples on to Whatman 3MM filter paper and immersion in ice-cold 10% (v/v) trichloroacetic acid/ 10 mM-Na2HPO4. Filters were extensively washed in the above buffer, dried, scintillation fluid was added, and they were counted for 32p.
RESULTS
We and others have previously reported that the specific thiol-alkylating agent NEM can inhibit the fl-subunit autophosphorylation of the insulin receptor in a time-and concentration-dependent manner Zick et al., 1983; Pike et al., 1984; Wilden et al., 1986) . Further, the insulin-receptor kinase activity was observed to be less sensitive to NEM inhibition in the absence of insulin than in the presence of insulin Wilden et al., 1986) . Consistent with theseprevious studies, the insulin-stimulated fl-subunit autophosphorylation of the purified human placental insulin receptor was found to be more susceptible to NEM inhibition than the untreated insulin receptors in both a time-and concentration-dependent manner (Fig. 1) . The half-maximal NEM inhibition of the initial rate of fl-subunit autophosphorylation in the presence of insulin . Autophosphorylation was carried out for 5 min at 23°C as described in the Experimental section. Laemmli (1970) sample buffer containing 100 mM-DTT was added before electrophoresis in a SDS/7% -polyacrylamide gel. The gels were processed for autoradiography. The fl-subunit was excised, hydrated, solubilized and prepared for scintillation counting as described in the Experimental section. occurred at 25 + 3/sM, whereas in the absence of insulin it occurred at 73 + 6/M (Fig. la) . The half-time for NEM inhibition of the f-subunit autophosphorylation (100 /M-NEM) in the presence of insulin was approx. 15 min, whereas in the absence of insulin it was approx. 30 min (Fig. lb) . Similarly, the thiol-specific reagent DTNB was also observed to inhibit the insulin-receptor fl-subunit autophosphorylation in a concentration- (Fig. 2a ) and time- (Fig. 2b) To determine if the differential sensitivity of the insulin-receptor kinase to thiol agents was due to inhibition of enzymic activity or to inhibition of the insulin receptor as a phospho-acceptor, we next examined the insulin-receptor exogenous-substrate protein kinase activity (Fig. 3) . NEM was again observed to inhibit in a concentration- (Fig. 3a) and time- (Fig. 3b) Samples were incubated with various concentrations of iodoacetamide for 1 h at 23 'C. Autophosphorylation was carried out for 5 min at 23 'C as described in the Experimental section. Laemmli (1970) sample buffer containing 100 mM-DTT was added before electrophoresis in a SDS/7% -polyacrylamide gel. The gels were processed for autoradiography. The fl-subunit was excised, hydrated, solubilized and prepared for scintillation counting as described in the Experimental section.
DTNB, the specific thiol reagent iodoacetamide was unable to inhibit the insulin-receptor f-subunit autophosphorylation in either the presence or the absence of insulin (Fig. 4) . At the highest concentration of iodoacetamide examined (10 mM), essentially no effect on the insulin-receptor,8-subunit autophosphorylation was detectable.
To determine if the iodoacetamide was reacting with the insulin receptor, we examined the ability of iodoacetamide to protect the fl-subunit autophosphorylation activity from NEM inhibition (Fig. 5) . In the absence of insulin, 100 ,tM-NEM inhibited the fl-subunit autophosphorylation by 60% (Fig. Sa) . Treatment of the insulin receptor with 100 1M-NEM, followed by 1.0 mMiodoacetamide, also resulted in a similar inhibition (63 % ) of f-subunit autophosphorylation. As previously observed (Fig. 4) , treatment of the insulin receptor with 1.0 mM-iodoacetamide had essentially no effect on the f-subunit autophosphorylating activity. However, treatment of the insulin receptor with 1.0 mM-iodoacetamide before incubation with 100 #,M-NEM resulted in a marked decrease (79%) in the ability of NEM to inhibit the f-subunit autophosphorylation.
Similarly to the studies in the absence of insulin, insulin receptors which were treated with insulin before NEM addition showed a 50% inhibition of the fl-subunit autophosphorylation. Further, iodoacetamide treatment had essentially no effect on the f-subunit autophosphorylation (Fig. Sb) . In contrast, incubation with 1.0 mM-iodoacetamide after insulin treatment markedly 120 r (a) these experiments, insulin was found to increase the ,-subunit autophosphorylation approx. 2.5-fold.
We have previously reported that, although the insulin-receptor a subunit has 3 times the number of cysteine residues compared with the fi subunit (Ebina et al., 1985; Ullrich et al., 1985) , only the , subunit is susceptible to [3H]NEM labelling at low concentrations . Consistent with these results, treatment of the insulin receptors with NEM, DTNB or iodoacetamide, up to 1.0 mm, had no significant effect on insulin binding (Fig. 6a) . At higher concentrations of these thiol reagents (10 mM) a small decrease in insulin binding was observed. In similar experiments, pretreatment of the 125j-insulin with NEM, DTNB or iodoacetamide before incubation with the insulin receptor also resulted in no significant change in insulin-binding activity at concentrations of these thiol reagents below I mm (Fig. 6b) .
We next investigated the effect of several oxidizing agents on the insulin-receptor ,-subunit autophosphoryl- Vol. 245 ating activity. A time-dependence of insulin receptors in the presence of H202 is shown in Fig. 7 . Oxidation of the insulin receptor by H202 appeared to indicate an increased sensitivity of fl-subunit autophosphorylation in the presence of insulin compared with that in the absence of insulin (Fig. 7, inset) . However, owing to the speed with which H202 inhibits the insulin-receptor ,-subunit autophosphorylation it was difficult clearly to observe a time-dependence. We therefore used the mixed-functionoxidation system of FeCl3/ascorbate, which allows finer control of the rate of oxidation of the insulin receptor. A time-dependence of insulin receptors in the presence of this mixed-function-oxidation system is shown in Fig. 8 phosphorylation of the insulin-receptor kinase Zick et al., 1983; Pike et al., 1984) . Further, the insulin-receptor protein kinase activity was observed to be more sensitive to NEM inhibition in the presence of insulin than in its absence Wilden et al., 1986) . These previous studies have led us to examine the effects of other thiol and oxidizing agents on the insulin-receptor f-subunit autophosphorylating activity. The data in Fig. 1 document the increased NEM-sensitivity of f-subunit autophosphorylation in the presence of insulin compared with in its absence, as previously reported. Similarly, DTNB also was found to inhibit the insulin-stimulated f-subunit autophosphorylation at an approx. 5-fold lower concentration than in the absence ofinsulin (Fig. 1) . We have also demonstrated an appropriate time-dependence for the inhibition of insulin-receptor f-subunit autophosphorylation in the presence and absence of insulin at a fixed concentration of thiol reagent. The differential sensitivity of the insulin-receptor kinase activity toward exogenously added substrate is shown by the similar concentration-and time-dependence effect of NEM. These studies argue against the possibility that the thiol reagents were affecting the phospho-acceptor portion of the insulin receptor, since only effects of the thiol reagents on the enzymic kinase activity of the insulin receptor were determined in the experiments involving exogenously added substrate.
In contrast, similar studies performed with the thiol-specific reagent iodoacetamide demonstrated no alteration in the fl-subunit autophosphorylation in either the presence or the absence of insulin. In order to ascertain whether or not iodoacetamide was actually reacting with the insulin receptor at the same site(s) as NEM, we examined the ability of iodoacetamide to protect against the NEM inhibition of f-subunit autophosphorylation. The data in Fig. 5 demonstrate that iodoacetamide can partially protect against the NEM inhibition of fl-subunit autophosphorylation in both the presence and the absence of insulin. These results suggest that the same critical thiol group(s) which are susceptible to NEM alkylation are also available to react with iodoacetamide. The lack of insulin-receptor kinase inhibition by iodoacetamide may be accounted for by the fact that this thiol reagent is a much smaller molecule than either NEM or DTNB, and therefore may not significantly alter the insulin-receptor structure. Alternatively, after the thiol reaction with iodoacetamide the critical thiol group(s) may still be able to participate in appropriate hydrogen bonding necessary for the kinase activity. This latter alternative appears unlikely, since iodoacetic acid treatment of the insulin receptor was also observed to have no significant effect on the insulin-receptor kinase activity (P. A. Wilden & J. E. Pessin, unpublished work).
We have previously reported that only the f, subunit of the insulin receptor kinase is susceptible to [3H]NEM labelling, although the a subunit contains 3 times the number of cysteine residues in the primary amino acid sequence (Ebina et al., 1985; Ullrich et al., 1985) . Consistent with this previous observation, preincubation of the insulin receptor with the various thiol reagents (NEM, DTNB or iodoacetamide) did not alter insulin binding over the concentration range which inhibits the fl-subunit autophosphorylating activity (Figs. 6a and 6b) . However, at much higher concentrations of these thiol reagents, a small decrease of insulin-binding activity was observed. This decrease cannot account for the inhibition of fl-subunit autophosphorylating activity.
Related studies have shown that the fl-subunit autophosphorylation of the insulin receptor is stimulated by reducing agents such as DTT and thioredoxin Fujita-Yamaguchi & Kathuria, 1985; Sweet et al., 1986; Wilden et al., 1986) . The observations that reduction activates and that specific thiol reagents inhibit the insulin-receptor kinase activity implied to us that oxidizing agents should also inhibit the insulin-receptor f-subunit autophosphorylation. This appears to be the case for H202 and is more clearly shown in the mixedoxidation system of FeCl3/ascorbate. Oxidation inhibits the insulin-stimulated f8-subunit autophosphorylation at a greater rate than the untreated insulin-receptor preparations (Fig. 8) . These data further support the hypothesis that, in the presence of insulin, an essential thiol group(s) has become more accessible to exogenously added reagents. Further elucidation of the critical structural elements of the insulin receptor are necessary future objectives in order to determine the molecular events responsible for the insulin-dependent trans-1987 membrane activation of the fl-subunit protein kinase domain.
